iCMLf Conversation: CML Highlights of EHA

Activity: Invited talks and oral presentationsInvited Keynote and Plenary Presentations


invited as CML expert by the International CML Foundation to present highlights of the past Conference of the European Haematology Association, EHA. Program: Clinical overview (Rüdiger Hehlmann) COVID-19 and CML (Rea, Breccia et al., S154) Personalized management and the new ELN Recommendations for treating CML (Hochhaus, Cortes et al, S153 / Saußele et al, S152) Monitoring MRD in CML: New developments (Cross) CML Genomics and the HARMONY PLUS project (Branford) Biological overview (Ilaria Pagani) Spotlight talk on Leukaemic stem cells (LSC's) on metabolism (Jones) Response, resistance and treatment-free remission in CML Mitochondrial DNA mutations are associated with response to imatinib in chronic myeloid leukemia patients (Pagani, S151) Loss of G0/G1 switch gene 2 (G0S2) in CML promotes TKI resistance by deregulating the mitochondrial electron transport chain (Gonzalez, S150) Q&A Session
Event titleiCMLf Conversation: CML Highlights of EHA
Event typeOther
Degree of RecognitionInternational